QA: ARVINAS INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001655759_2023_ARVINAS_INC.pdf

Logs

Graph

Absolute values for 0001655759, ARVINAS INC.

  xvar xval
0 AssetsCurrent 1,240,200,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 13,400,000
3 remainder_Assets 15,200,000
4 LiabilitiesCurrent 295,100,000
5 LiabilitiesNoncurrent 408,800,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 79,600,000
9 ResearchAndDevelopmentExpense 315,000,000
10 remainder_Expenses 20,900,000
11 remainder_Revenues 131,400,000
12 remainder_NetIncome 1,600,000
13 remainder_ComprehensiveNetIncome -14,500,000
  yvar yval
0 Assets 1,268,800,000
1 Liabilities 703,900,000
2 Expenses 415,500,000
3 Revenues 131,400,000
4 StockholdersEquity 564,900,000
5 NetIncome -282,500,000
6 ComprehensiveNetIncome -289,750,000
7 BaseVar 1,267,850,000
8 EconomicCapitalRatio 0.691

Edgar->Model Mapping

Feature Distribution

Change over Time